Cite

HARVARD Citation

    Nicolas, J. et al. (2016). Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action. Epilepsia. pp. 201-209. [Online]. 
  
Back to record